President of Research and Development and Chief Medical Officer @ GT Biopharma (April 2021 - December 2022)
Board Member @ GT Biopharma (November 2020 - April 2021)
Chief Medical Officer @ (April 2021 - December 2022)
Chief Medical Officer @ Celularity (December 2020 - April 2021)
Hematology-Oncology Consultant @ Gregory Berk, MD, PC (February 2017 - December 2020)
Chief Medical Officer @ (April 2016 - January 2017)
President and Chief Medical Officer @ Sideris Pharmaceuticals (January 2014 - February 2016)
Assist Clinical Professor @ (January 1990 - January 2003)
Greg Berk Education
Joan & Sanford I. Weill Medical College of Cornell University
Doctor of Medicine (MD) (Internal Medicine, Heme-Onc)
1984-1990
Case Western Reserve University School of Medicine
MD (Medicine)
1980-1984
Tulane University
BS summa cum laude (biochemistry)
1976-1980
Greg Berk Skills
Medicine
Internal Medicine
Biomarker Discovery
Drug Development
Cancer
Clinical Trials
Lifesciences
Drug Discovery
Pharmaceutical Industry
Medical Oncology
Hematology
Biotechnology
Microsoft Word
Project Management
Microsoft Excel
Management
Leadership
PowerPoint
Microsoft Office
Greg Berk Summary
Greg Berk, based in United States, is currently a Chief Medical Officer at Allorion Therapeutics. Greg Berk brings experience from previous roles at Beyond Cancer, Ltd., XLINK Therapeutics, Inflection Biosciences Ltd and GT Biopharma. Greg Berk holds a 1984 - 1990 Doctor of Medicine (MD) in Internal Medicine, Heme-Onc @ Joan & Sanford I. Weill Medical College of Cornell University. With a robust skill set that includes Medicine, Internal Medicine, Biomarker Discovery, Drug Development, Cancer and more. Greg Berk has 1 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Greg Berk?
Find contact details for 700 million professionals.